Cardiovascular Physiology and Pharmacology

Similar documents
Cardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart

Heart Failure (HF) Treatment

Cardiovascular Physiology

PHYSIOLOGY MeQ'S (Morgan) All the following statements related to blood volume are correct except for: 5 A. Blood volume is about 5 litres. B.

Cardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007

Vasoactive Medications. Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis

Chapter 13 The Cardiovascular System: Cardiac Function

Principles of Biomedical Systems & Devices. Lecture 8: Cardiovascular Dynamics Dr. Maria Tahamont

Heart Pump and Cardiac Cycle. Faisal I. Mohammed, MD, PhD

Review of Cardiac Mechanics & Pharmacology 10/23/2016. Brent Dunworth, CRNA, MSN, MBA 1. Learning Objectives

The Cardiovascular System

AUTONOMIC DRUGS: ADRENOCEPTOR AGONISTS AND SYMPATHOMIMETICS. Lecture 4

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

BIOL 219 Spring Chapters 14&15 Cardiovascular System

Anaesthesia. Update in. An Introduction to Cardiovascular Physiology. James Rogers Correspondence

TEACH Lesson Plan Manual for Herlihy s The Human Body in Health and Illness 5 th edition

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

During exercise the heart rate is 190 bpm and the stroke volume is 115 ml/beat. What is the cardiac output?

Drugs Used in Heart Failure. Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia

BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Chapter 9, Part 2. Cardiocirculatory Adjustments to Exercise

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

11/10/2014. Muscular pump Two atria Two ventricles. In mediastinum of thoracic cavity 2/3 of heart's mass lies left of midline of sternum

Blood pressure. Formation of the blood pressure: Blood pressure. Formation of the blood pressure 5/1/12

Cardiac Output (C.O.) Regulation of Cardiac Output

CARDIOVASCULAR SYSTEM

Cardiac Output (CO) Definitions. Cardiac Output and venous return. Dr Badri Paudel GMC. Cardiac Output. Venous Return

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

*Generating blood pressure *Routing blood: separates. *Ensuring one-way blood. *Regulating blood supply *Changes in contraction

PITTMed Cardiology. Pharmacology Modules. Learning Objectives. Site Contents. Fall 2018

Blood Pressure Regulation. Slides 9-12 Mean Arterial Pressure (MAP) = 1/3 systolic pressure + 2/3 diastolic pressure

The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic

The Anatomy and Physiology of the Circulatory System

AS Level OCR Cardiovascular System

Pharmacology of inotropes and vasopressors

(D) (E) (F) 6. The extrasystolic beat would produce (A) increased pulse pressure because contractility. is increased. increased

SIKLUS JANTUNG. Rahmatina B. Herman

Properties of Pressure

Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide

a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline, isoprenaline, dopamine, dobutamine

Therefore MAP=CO x TPR = HR x SV x TPR

Δακτυλίτιδα και Ινότροπα Φάρμακα στην Καρδιακή Ανεπάρκεια. Ι.Κανονίδης

Nothing to Disclose. Severe Pulmonary Hypertension

10. Thick deposits of lipids on the walls of blood vessels, called, can lead to serious circulatory issues. A. aneurysm B. atherosclerosis C.

The circulatory system

Topics to be Covered. Cardiac Measurements. Distribution of Blood Volume. Distribution of Pulmonary Ventilation & Blood Flow

Approximately the size of your fist Location. Pericardial physiology

Introduction to Physiology (Course # 72336) 1. Adi Mizrahi Textbook Chapter 12

10/23/2017. Muscular pump Two atria Two ventricles. In mediastinum of thoracic cavity 2/3 of heart's mass lies left of midline of sternum

WRITER TRISTAN WALKER TABLE OF CONTENTS. The Basics of cardiac pharmacology 2007

Cardiovascular System: The Heart

Cardiovascular Physiology

Electrical Conduction

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

DIAGNOSIS AND MANAGEMENT OF ACUTE HEART FAILURE

Cardiovascular regulation. Neural and hormonal Regulation Dr Badri Paudel GMC. 1-Local factors (autoregulation) Control of Blood Flow

THE CARDIOVASCULAR SYSTEM. Heart 2

REGULATION OF CARDIOVASCULAR SYSTEM

Blood Pressure Regulation. Faisal I. Mohammed, MD,PhD

-12. -Ensherah Mokheemer - ABDULLAH ZREQAT. -Faisal Mohammad. 1 P a g e

HOW LOW CAN YOU GO? HYPOTENSION AND THE ANESTHETIZED PATIENT.

Circulation: Chapter 25. Cardiac Output. The Mammalian Heart Fig Right side of the heart

Cardiovascular system

Part 3a. Physiology: the cardiovascular system

I intend to discuss an unapproved/investigative use of a commercial product/device in my presentation

Cardiac Output 1 Fox Chapter 14 part 1

Cardiovascular Physiology

0. Where do you think blood tends to pool when a witch flies on her broomstick? (1 point)

The Cardiovascular System

BUSINESS. Articles? Grades Midterm Review session

Chapter 6: The Cardiovascular System and Its Control

ADRENERGIC AGONISTS. Course: Integrated Therapeutics 1. Lecturer: Dr. E. Konorev. Date: September 16, Materials on: Exam #2

Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50

Dr. Vishaal Bhat. anti-adrenergic drugs

Swans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall

Swans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall

Heart Failure. Dr. Alia Shatanawi

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

The Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018

IP: Regulation of Cardiac Output

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Examination Period 3: 2016/17

TOPIC : Cardiogenic Shock

Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy

The Heart. Size, Form, and Location of the Heart. 1. Blunt, rounded point; most inferior part of the heart.

Blood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD

Chapter 20: Cardiovascular System: The Heart

The Autonomic Nervous System Introduction. Autonomic Nervous System - Overview

Systemic Pharmacology Lecture 7: Neuropharmacology

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

Treatment of Congestive Heart Failure

Age-related changes in cardiovascular system. Dr. Rehab Gwada

Cardiovascular System. Heart

Levosimendan, a New Inotropic and Vasodilator Agent Wolfgang G. Toller, M.D.,* Christian Stranz, M.D.

Hemodynamic improvement upon levosimendan treatment in low cardiac output patients following coronary artery bypass graft

Transcription:

Cardiovascular Physiology and Pharmacology Peter Paal Perioperative Medicine, Barts Heart Centre St. Bartholomew s Hospital, Barts Healt NHS Queen Mary University of London and Department of Anaesthesiology and Intensive Care University Hospital Innsbruck, Austria

Thanks to Prof. Dr. W. Toller, MBA, DESA Head of the Division of Cardiovascular Anesthesiology Department of Anesthesiology and Intensive Care Medicine Medical University of Graz Austria

CARDIOVASCULAR PHYSIOLOGY

Myocardial contraction and Frank-Starling-Relationship

Actin-Myosin-Filaments

Troponin complex I = Inhibits interaction between actin and myosin when phosphorylated C = Ca 2+ binding Protein T = Tropomyosin-binding

Frank Starling law of the heart (Starling's law) Stroke volume in response to end- diastolic volume Volume stretches ventricular wall more forceful contraction Mechanism: Stretching increases affinity of troponin C for calcium greater number of actinmyosin cross-bridges form

Relation of resting sarcomere length on contractile force

Maximal force is generated with an initial sarcomere length of 2.2 µm Tension (%) 100 50 0

% Cell shortening Sensitivity of myofilaments for Ca 2+ 15 Control 10 Desensitization 5 0 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 Intracellular Ca2+ concentration (nm)

% Cell shortening Sensitivity of myofilaments for Ca 2+ 15 Sensitization Control 10 5 0 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 Intracellular Ca 2+ concentration (nm)

Relative Force Development Change of myofilament sensitivity to Ca 2+ 1,2 1,0 0,8 0,6 0,4 a b Temperature Protons ADP Phosphate 0,2 0,0 8 7 6 pca ( log[ca])

The cardiac cycle - Relation of Pressure against Volume

Left ventricular pressure-volume loop Stroke work = SV x Pressure

Sources of errors Does aortic pressure peak at end of systole? Does AV open when ventricular contraction begins? Volume change during isometric contraction? All valves closed at the onset of systole?

Systole Different Phases Isovolumetric contraction phase All valves closed Ejection phase Maximum ejection Reduced ejection

Diastole Different Phases Isovolumetric relaxation Ends with AV opening Rapid filling phase Diastasis Atrial systole Ends with start of systole 80% of the blood flows passively down to the ventricles

Duration (sec) of cardiac cycle phases in adult Isovolumetric contraction 0,05 Maximum ejection 0,09 Reduced ejection 0,13 Total systole 0,27 Protodiastole 0,04 Isovolumetric relaxation 0,08 Rapid inflow 0,11 Diastasis 0,19 Atrial systole 0,11 Total diastole 0,53 atz, Physiology of the Heart 2nd ed., p363; 1992 Raven press Heart Rate 75/min S:D = 1:2

Relationship of duration of systole + diastole with increasing heart rate

End-systolic and end-diastolic pressure-volume relationship Inotropy Lusitropy

Decreased contractility, increased end-diastolic volume

Vasoconstriction, fluid retention

Increased contractility, increased lusitropy

Wiggers Diagram - Relation of Pressures, Volume and ECG over Time

Aortic valve opens Aortic valve closes Wiggers- Diagram Mitral valve closes Mitral valve opens

Central venous pressure waveform atrial systole cusps bulge into atrium as AV closes Filling of atria; concomitant ventricular systole x y atrial relaxation; ventricle contracts, downward movement of base AV opens; rapid drainage into ventricle

Simultaneous plotting of ECG and central-venous pressure

Myocardial Perfusion, Oxygen Supply, Oxygen Demand

Anatomy of the coronary arteries Frank Netter, 1990

SYSTOLE DIASTOLE Arterial Blood Pressure 120 100 80 Left Coronary Artery Flow 0 Flow Right Coronary Artery Flow 0 Flow

Main determinants of myocardial oxygen supply O 2 -Content of coronary blood Haemoglobin Coronary perfusion Coronary resistance Diastolic aortic pressure LVEDP Heart Rate Main natural mechanism to increase supply: Coronary vasodilation (!) Coronary oxygen extraction already maximal at rest!

Main determinants of myocardial oxygen demand Heart Rate Tachycardia increases oxygen demand Bradycardia decreases oxygen demand (e.g. b-blockers)

Relationship of duration of systole + diastole with increasing heart rate

Main determinants of myocardial oxygen demand Heart Rate Tachycardia increases oxygen demand Bradycardia decreases oxygen demand (e.g. b-blockers) Myocardial contractility Inotropes increase oxygen demand (e.g. epinephrine) b-blockers decrease oxygen demand

Effects of Milrinone or Levosimendan on Myocardial Oxygen Consumption Kaheinen, J Cardiovasc Pharmacol 43:555, 2004

Main determinants of myocardial oxygen demand Heart Rate Tachycardia increases oxygen demand Bradycardia decreases oxygen demand (e.g. b-blockers) Myocardial contractility Inotropes increase oxygen demand (e.g. epinephrine) b-blockers decrease oxygen demand Wall tension of the myocardium High wall tension increases oxygen demand Decrease of wall tension decreases oxygen demand

Wall tension of the myocardium Laplace s Law T = p x r 2h T = wall tension p = internal pressure r = internal radius h = wall thickness Increase in preload ± afterload increases wall tension e.g. Nitrates decrease wall tension Dilated cardiomyopathy increases wall tension Ventricular hypertrophy decreases wall tension

Same pressure, same stroke volume, higher wall stress

Cardiovascular Reflexes

Cardiovascular reflexes = neural feedback loops Afferent Activity Heart Vasculature Regulation and modulation of cardiac function CNS Vasomotor Center Efferent Activity

Cardiovascular reflexes Baroreceptor Reflex Bainbridge-Reflex Bezold-Jarisch-Reflex Valsalva Manoeuvre

Baroreceptor Reflex Definition Homeostatic mechanism for maintaining blood pressure Elevated blood pressure reflexively decreases heart rate + blood pressure Decreased blood pressure increases heart rate + blood pressure

Baroreceptors Afferents

Target: Solitary tract nucleus = vasomotor center Pressure sensing results in greater afferent activity which inhibits vasomotor center

Baroreceptor Reflex Efferents To heart Primarily governs rate To kidney To peripheral vasculature Primarily governs degree of vessel constriction Subdivisions Carotid baroreceptor reflex - Heart Aortic baroreceptor reflex - Vascular

Bainbridge-Reflex Definition Rapid intravenous infusion of volume produces tachycardia Tachycardia is reflex in origin Stretch receptors in the right and left atria Vagus nerve constitutes afferent limb Withdrawal of vagal tone primary efferent limb Bainbridge, The influence of venous filling upon the rate of the heart. J Physiol 50:65 84, 1915

Bezold-Jarisch-Reflex Definition Inhibition of sympathetic outflow to blood vessels and the heart Mediated by mechano- and chemosensitive receptors located in the wall of the ventricles Preservation of the heart Vasodilation during heart failure Hypotension Bradycardia Apnea possible Possible cause of profound bradycardia and circulatory collapse after spinal anesthesia Albert von Bezold (1836 1868) and Adolf Jarisch Jr. (1891 1965)

The Valsalva Manoeuvre Test of Sympathetic nerve system function Parasympathetic nerve system function Straining by blowing into mouthpiece against a pneumatic resistance while maintaining a pressure of 40 mmhg for 15 sec

Four phases of the Valsalva Manoeuvre 1. BP via mechanical factors 2. BP (due to venous return); reflex HR and SVR return of BP despite SV 3. BP via mechanical factors after expiratory pressure is released 4. Venous return and SV (back to normal over several min), but PVR and CO cause BP and HR (reflex)

Four phases of the Valsalva Manoeuvre

CARDIOVASCULAR PHARMACOLOGY

Synthesis of dopamine, norepinephrine and epinephrine (1) Phenylalanine NH 2 CH 2 CH 2 COOH Tyrosine NH 2 HO CH 2 CH 2 COOH HO HO Dopa NH 2 CH 2 CH 2 COOH

Synthesis of dopamine, norepinephrine and epinephrine (2) HO Dopamin CH 2 CH 2 NH 2 HO HO Norepinephrine OH CH CH 2 NH 2 HO HO Epinephrine OH CH CH 2 NH CH 3 HO Dobutamine, Phenylephrine, Efedrine are synthetic!

Degradation of catecholamines Example: Dopamine

Catecholamines act by stimulating adrenergic receptors b-adrenergic receptors b 1 Cardiac stimulation (positive inotropic, lusitropic, chronotropic) Agonists, e.g. Isoprenaline, Dobutamine, Epinephrine Antagonists, e.g. Esmolol, Metoprolol, Atenolol, Bisoprolol, Carvedilol b 2 Smooth muscle relaxation, (increased myocardial contractility) Agonists, e.g. Salbutamol, Terbutalin, Salmeterol Antagonists, e.g. Propranolol b 3 Enhancement of lipolysis, smooth muscle relaxation Agonists + Antagonists, in development e.g. Solabegron

b 1 -Adrenoceptor Ca 2+ Dobutamine, Epinephrine G s A C Milrinone P ATP TnI Actin TnC camp PDE Protein Kinase A Ca 2+ Ca 2+ Sarc. Ret. Ca 2+ Myosin Ca 2+ PL ATP Ca 2+

Catecholamines act by stimulating adrenergic receptors a-adrenergic receptors a 1 Vasoconstriction, renal sodium retention, decreased gastrointestinal motility Agonists, e.g. Norepinephrine, Phenylephrine, Etilefrine, Metaraminol, Methoxamine, Epinephrine Antagonists, e.g. Phentolamine, Phenoxybenzamine, Prazosin, Labetalol, Carvedilol a 2 Central inhibition of sympathetic activity ( vasodilation, bradycardia) Agonists, e.g. Clonidine, Dexmedetomidine Antagonists, e.g. Phentolamine, Tolazoline

a1 a2 b G q G i G s Phospholipase C Adenylatecyclase Adenylatecyclase PIP 2 DAG ATP camp ATP camp IP 3 Ca 2+ Smooth muscle contraction Ca 2+ Inhibition of transmitter release Smooth muscle contraction Heart muscle contraction Smooth muscle relaxation glycogenolysis

Dopamine Stimulates Dopamine-Receptors at low doses (1 3 µg/kg/min) Various subtypes of Dopamine-receptors (D 1 -D 5 ) High receptor density in the proximal tubules of the kidney natriuresis, diuresis High receptor density in the pulmonary artery vasodilation Additionally stimulates b 1 -Receptors at moderate doses (3 10 µg/kg/min) Additionally stimulates a 1 -Receptors at high doses (> 10 µg/kg/min)

Effects of various catecholamines on different adrenergic receptors Cardiac b-receptors Vascular a-receptors Vascular b-receptors Norepinephrine + ++ - Epinephrine ++ + ++ Isoproterenol +++ - +++ Dopamine + + - Dobutamine ++ - (+) Phenylephrine - +++ - Ephedrine + ++ +

Comparison of clinical effects of inotropes Epinephrine, Norepinephrine Dopamine Dobutamine Milrinone Levosimendan Vasoconstriction Enhanced inotropy Increased heart rate Myocardial O 2 consumption Tachyarrhythmias Offset of action min hours hours - days

K + K + Digoxin 3 K + Na + 2 Na + Na + Ca 2+ ATPase Exchanger Ca 2+ Na + Na + Myosin TnI Actin TnC

Myocardial Contraction and Frank-Starling-Relationship The cardiac cycle- Relation of Pressure against Volume Wiggers Diagram- Relation of Pressures, Volume and ECG over Time Myocardial Perfusion, Oxygen Supply, Oxygen Demand Cardiovascular Reflexes Cardiovascular Pharmacology-Synthesis, Metabolism and Action of Catecholamines

Questions? Thank you!